ScholarIQanswers from OpenAlex & ORCID
Jessie Wang
ResearcherPublications, citations & collaboration network
Jessie Wang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jessie Wang have?
ScholarIQindexed works
Jessie Wang has 108 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jessie Wang have?
ScholarIQcitation count
Jessie Wang has 2,785 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jessie Wang?
ScholarIQh-index
Jessie Wang has an h-index of 22 in OpenAlex.
What is the i10-index of Jessie Wang?
ScholarIQi10-index
Jessie Wang has an i10-index of 33 in OpenAlex.
What is the ORCID of Jessie Wang?
ScholarIQorcid
The ORCID for Jessie Wang is on the source record.
What is the OpenAlex record for Jessie Wang?
ScholarIQopenalex
The OpenAlex for Jessie Wang is on the source record.
What are the most-cited papers on Jessie Wang?
ScholarIQmost cited works
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis
Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury, Jessie Wang, Ming Chang, Donglu Zhang, Yan Song, Janice Pursley, Rebecca A. Boyd, Charles Frost
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects
Charles Frost, Sunil Nepal, Jessie Wang, Alan Schuster, Wonkyung Byon, Rebecca A. Boyd, Zhigang Yu, Andrew Shenker, Yu Chen Barrett, Rogelio Mosqueda‐Garcia, Frank LaCreta
Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
Vijay Upreti, Jessie Wang, Yu Chen Barrett, Wonkyung Byon, Rebecca A. Boyd, Janice Pursley, Frank LaCreta, Charles Frost
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban
Ming Chang, Zhigang Yu, Andrew Shenker, Jessie Wang, Janice Pursley, Wonkyung Byon, Rebecca A. Boyd, Frank LaCreta, Charles Frost
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study
Jeffrey S. Hyams, Sonia Thomas, Nathan Gotman, Yael Haberman, Rebekah Karns, Melanie Schirmer, Angela Mo, David R. Mack, Brendan Boyle, Anne M. Griffiths, Neal S. LeLeiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel R. Rosh, Robert N. Baldassano, Ashish Patel, Marian Pfefferkorn, Anthony Otley, Melvin B. Heyman, Joshua D. Noe, Maria Oliva‐Hemker, Paul A. Rufo, Jennifer Strople, David Ziring, Stephen L. Guthery, Boris Sudel, Keith Benkov, Prateek Wali, Dedrick E. Moulton, Jonathan Evans, Michael D. Kappelman, Miriam Marquis, Francisco Sylvester, Margaret H. Collins, Suresh Venkateswaran, Marla Dubinsky, Vin Tangpricha, Krista Spada, Bradley Saul, Jessie Wang, José Serrano, Kevin A. Hommel, Urko M. Marigorta, Greg Gibson, Ramnik J. Xavier, Subra Kugathasan, Thomas D. Walters, Lee A. Denson